October 27, 2025, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXII, No. 15 – October 27, 2025 Issue

In yet another shuffling of the in vitro diagnostics (IVD) space, Hologic announced on Oct. 21 that it was being acquired by private equity firms Blackstone and TPG for $18.3 billion. The deal will take Hologic off the Nasdaq, likely in early 2026. TPG and Blackstone lauded Hol…

Read More

---

After Regaining Outreach, Lab Grows it by $10M

By Janette Wider | From the Volume XXXII, No. 14 – October 6, 2025 Issue

CEO SUMMARY: In this case study, Kootenai Health in Idaho explains how taking back lab outreach services from a commercial lab company can improve physician satisfaction, enhance patient care, and increase revenue. Although the transition was bumpy, within two years of bri…

Read More

---

National Lab Company Briefs

By Scott Wallask | From the Volume XXXII, No. 14 – October 6, 2025 Issue

Quest, Labcorp Push Alzheimer’s Test Quest Diagnostics and Labcorp are now offering Fujirebio’s Lumipulse test, the first Food and Drug Administration-cleared blood-based assay for con…

Read More

---

Quest, Labcorp Discuss PAMA and M&A with Investors

By Mark Terry | From the Volume XXXII, No. 13 – September 15, 2025 Issue

WHILE LAUDING EXCELLENT GROWTH FOR THE SECOND QUARTER, executives at Labcorp and Quest Diagnostics also expressed concern over the Protecting Access to Medicare Act (PAMA), which was passed by Congress in 2014 and which continues to cause uncertainty as full implementation is repeatedly…

Read More

---

An Insider’s Observances of Lab Outreach Deals

By R. Lewis Dark | From the Volume XXXII, No. 12 – August 25, 2025 Issue

THERE ARE MANY WAYS TO VIEW CLINICAL LABORATORY OUTREACH ACQUISITIONS and the enormous amount of money changing hands in these deals. From one point of view, those fearful of the continued expansion of national lab giants like Labcorp and Quest Diagnostics may shive…

Read More

---

August 4, 2025, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXII, No. 11 – August 4, 2025 Issue

In a filing with the US Securities and Exchange Commission, UnitedHealth Group (UHG) has acknowledged it is under investigation by the US Department of Justice (DOJ). “[UHG] proactively reached out to the Department of Justice after reviewing media reports about investigations into ce…

Read More

---

Leveraging Data to Create Lab and Healthcare Efficiencies

By Robert Michel | From the Volume XXXII, No. 8 – June 2, 2025 Issue

CEO SUMMARY: In this exclusive interview with The Dark Report, Bradley Bostic, founder, chair, and CEO of healthcare and laboratory data intelligence company hc1 discusses trends in healthcare, how to position clinical laboratories as a strategic asset, and ways to analyze…

Read More

---

Quest, Labcorp CEOs Discuss Tariff Strategies with Investors

By Robert Michel | From the Volume XXXII, No. 7 – May 12, 2025 Issue

Leaders at Labcorp and Quest Diagnostics indicated that they are prepared to weather at least the early months of the unfolding tariff war that is upending the global economy. “There will be some impact from …

Read More

---

May 12, 2025, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXII, No. 7 – May 12, 2025 Issue

Yet another clinical laboratory has sold off part of its services to a national commercial lab. Labcorp announced on April 21 that it had finalized its acquisition of North Mississippi Health Services’ (NMHS) ambulatory outreach laboratory business. A…

Read More

---

In the Past, Labs Used Courts to Thwart Feds

By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue

CEO SUMMARY: A federal judge’s recent decision to vacate the FDA’s final rule on laboratory developed tests harkens back to a 2008 case where clinical labs stopped a CMS competitive bidding project. In the earlier case, legal risks led the government to back down. The …

Read More

---